Author

Peter J. Kourlas

Observed names: Peter J Kourlas, Peter Kourlas

Institution: Columbus Oncology and Hematology Associates

Observed institutions: National Institutes of Health, Helsinki University Hospital, Columbus Oncology and Hematology Associates, Sidney Kimmel Cancer Center, Upper Arlington Public Library, National Cancer Institute, The Ohio State University

OpenAlex ID: A5030100301

Identification of a gene at 11q23 encoding a guanine nucleotide exchange factor: Evidence for its fusion with MLL in acute myeloid leukemia

2000 · Peter J. Kourlas, Matthew P. Strout, et al. · Proceedings of the National Academy of Sciences · 234

Phase 1 and pharmacodynamic studies of G3139, a Bcl-2 antisense oligonucleotide, in combination with chemotherapy in refractory or relapsed acute leukemia

2002 · Guido Marcucci, John C. Byrd, et al. · Blood · 222

Germ-line PHD1 and PHD2 mutations detected in patients with pheochromocytoma/paraganglioma-polycythemia

2014 · Chunzhang Yang, Zhengping Zhuang, et al. · Journal of Molecular Medicine · 146

Cyclosporine or steroids as an adjunct to plasma exchange in the treatment of immune-mediated thrombotic thrombocytopenic purpura

2017 · Spero R. Cataland, Peter J. Kourlas, et al. · Blood Advances · 74

S1417CD: A Prospective Multicenter Cooperative Group-Led Study of Financial Hardship in Metastatic Colorectal Cancer Patients

2021 · Veena Shankaran, Joseph M Unger, et al. · JNCI Journal of the National Cancer Institute · 72

Cumulative incidence of financial hardship in metastatic colorectal cancer patients: Primary endpoint results for SWOG S1417CD.

2020 · Veena Shankaran, Joseph M. Unger, et al. · Journal of Clinical Oncology · 9

Macrophage Activation Syndrome (MAS) in a Recently Released Prisoner with Systemic Lupus Erythematosus (SLE)

2018 · Robert Szulawski, Peter J. Kourlas, et al. · American Journal of Case Reports · 6

Fatigue and Abdominal Fullness in a 36-Year-Old Woman

1998 · Thomas P. Archer, Peter J. Kourlas, et al. · Hospital Practice · 4

Cumulative incidence of financial hardship in metastatic colorectal cancer (mCRC) patients (pts): Primary endpoint results for SWOG S1417CD.

2020 · Veena Shankaran, Joseph M. Unger, et al. · Journal of Clinical Oncology · 2

Design and accrual of S1417CD: Development of a prospective financial impact assessment tool in patients with metastatic colorectal cancer (mCRC).

2019 · Veena Shankaran, Joseph M. Unger, et al. · Journal of Clinical Oncology · 1

A 20-Year-Old Woman with Jaundice

2000 · Peter J. Kourlas, Thomas P. Archer, et al. · Hospital Practice · 1

N0937(Alliance): Final clinical results and correlative data from the phase II trial of cisplatin (C) and the novel agent brostallicin (B) in patients with metastatic triple-negative breast cancer (mTNBC).

2013 · Alvaro Moreno-Aspitia, Heshan Liu, et al. · Journal of Clinical Oncology

Works count: 12

Citation count: 771

H-index: 6

I10-index: 5